Cargando…
Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566861/ https://www.ncbi.nlm.nih.gov/pubmed/33134941 http://dx.doi.org/10.1097/CCE.0000000000000246 |
| _version_ | 1783596209647124480 |
|---|---|
| author | Slessarev, Marat Fraser, Douglas D. |
| author_facet | Slessarev, Marat Fraser, Douglas D. |
| author_sort | Slessarev, Marat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7566861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75668612020-10-29 Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets Slessarev, Marat Fraser, Douglas D. Crit Care Explor Letter to the Editor Lippincott Williams & Wilkins 2020-10-15 /pmc/articles/PMC7566861/ /pubmed/33134941 http://dx.doi.org/10.1097/CCE.0000000000000246 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Letter to the Editor Slessarev, Marat Fraser, Douglas D. Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title | Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title_full | Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title_fullStr | Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title_full_unstemmed | Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title_short | Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets |
| title_sort | anticytokine therapies in severe coronavirus disease 2019 should be informed by detailed inflammatory profiling and specific therapeutic targets |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566861/ https://www.ncbi.nlm.nih.gov/pubmed/33134941 http://dx.doi.org/10.1097/CCE.0000000000000246 |
| work_keys_str_mv | AT slessarevmarat anticytokinetherapiesinseverecoronavirusdisease2019shouldbeinformedbydetailedinflammatoryprofilingandspecifictherapeutictargets AT fraserdouglasd anticytokinetherapiesinseverecoronavirusdisease2019shouldbeinformedbydetailedinflammatoryprofilingandspecifictherapeutictargets |